News & Updates
Showing Endocrinology articles
Showing

SGLT-2 inhibitors stop kidney stone recurrence in T2D patients with nephrolithiasis, gout
Use of an SGLT-2 inhibitor, compared with a GLP-1 receptor agonist or a DPP-4 inhibitor, helps to prevent nephrolithiasis from recurring in patients with type 2 diabetes (T2D) and pre-existing nephrolithiasis or gout, as shown in target trial emulation studies.

New tool measures parent’s perceptions of obesity impact on child’s life
A parent-proxy, obesity-specific health-related quality of life (HRQoL) measure, Sizing Them Up (STU), demonstrates acceptable internal consistency, test-retest reliability, construct validity, and convergent validity in adolescents undergoing weight management treatment in Singapore, reports a study.

ChatGPT may aid in diabetes, MetS management, but with caveat
Artificial intelligence (AI) chatbots, such as ChatGPT, can be used by clinicians as a resource for disease management and education, but researchers of a recent study urge users to consider the “gaps” seen in managing individuals with type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS).






